OBJECTIVE: The purpose of this study is to identify factors which predict adherence in stroke survivors. DESIGN: This is a longitudinal study where 180 stroke survivors were assessed 1 year after their first ischaemic stroke. The relationship between adherence and illness and medication beliefs was tested at baseline (time 1) and again 5-6 weeks later (time 2). MAIN OUTCOME MEASURES: The main outcome measures used in this study are Medication Adherence Report Scale and urinary salicylate levels. RESULTS: Four variables predicted time 1 poor adherence: (1) younger age, (2) increased specific concerns about medications, (3) reduced cognitive functioning and (4) low perceived benefit of medication. Three out of these four variables were again predictive of time 2 adherence and accounted for 24% of the variance: (1) younger age, (2) increased specific concerns about medications and (3) low perceived benefit of medication. The urinary salicylate assay failed to differentiate between patients taking and not taking aspirin. CONCLUSION: Interventions to improve adherence should target patients' beliefs about their medication.
OBJECTIVE: The purpose of this study is to identify factors which predict adherence in stroke survivors. DESIGN: This is a longitudinal study where 180 stroke survivors were assessed 1 year after their first ischaemic stroke. The relationship between adherence and illness and medication beliefs was tested at baseline (time 1) and again 5-6 weeks later (time 2). MAIN OUTCOME MEASURES: The main outcome measures used in this study are Medication Adherence Report Scale and urinary salicylate levels. RESULTS: Four variables predicted time 1 poor adherence: (1) younger age, (2) increased specific concerns about medications, (3) reduced cognitive functioning and (4) low perceived benefit of medication. Three out of these four variables were again predictive of time 2 adherence and accounted for 24% of the variance: (1) younger age, (2) increased specific concerns about medications and (3) low perceived benefit of medication. The urinary salicylate assay failed to differentiate between patients taking and not taking aspirin. CONCLUSION: Interventions to improve adherence should target patients' beliefs about their medication.
Authors: Rebecca J Lank; Lynda D Lisabeth; Brisa N Sánchez; Darin B Zahuranec; Kevin A Kerber; Lesli E Skolarus; James F Burke; Deborah A Levine; Erin Case; Devin L Brown; Lewis B Morgenstern Journal: Neurology Date: 2019-01-04 Impact factor: 9.910
Authors: Claudia M Lora; Alexander W Sokolovsky; Daniel R Touchette; Jing Jin; Xiaojing Hu; Weihua Gao; Ben S Gerber Journal: Ethn Dis Date: 2013 Impact factor: 1.847
Authors: Teresa M Damush; Laura Myers; Jane A Anderson; Zhangsheng Yu; Susan Ofner; Gloria Nicholas; Barbara Kimmel; Arlene A Schmid; Thomas Kent; Linda S Williams Journal: Transl Behav Med Date: 2016-09 Impact factor: 3.046
Authors: Ian M Kronish; Michael A Diefenbach; Donald E Edmondson; L Alison Phillips; Kezhen Fei; Carol R Horowitz Journal: J Gen Intern Med Date: 2013-01-04 Impact factor: 5.128